AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2001 JUN 20 - (NewsRx.com & NewsRx.net) --
VaxGen, Inc. (VXGN) presented laboratory data at a scientific conference indicating that the company's HIV/AIDS vaccine induces immune responses capable of preventing infection from a broader array of HIV strains than previously thought.
This represents new evidence that the vaccine, AIDSVAX, may be effective against HIV strains found in nature, also known as primary isolates, or "wild type" strains, the company says. The finding was made possible by a new assay developed at VaxGen that allowed company scientists to more accurately measure how well antibodies induced by the vaccine prevented cell-to-cell transmission of the virus.
Cell-to-cell transmission, in which a diseased human cell infects healthy ones, is considered one of the major routes of spreading HIV infection. The new assay showed that antibodies induced by the vaccine bound to infected T cells. Furthermore, the antibodies prevented the diseased cells from infecting ...
Source: HighBeam Research, Vaccine Protects Against Array Of HIV Strains.(Brief Article)